Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Moodys
Argus Health
US Department of Justice
Teva
Dow
Citi
Cipla

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017426

« Back to Dashboard

NDA 017426 describes DESONIDE, which is a drug marketed by G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Glenmark Pharms Ltd, and Hi-tech Pharmacal, and is included in thirteen NDAs. It is available from eleven suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
Summary for 017426
Tradename:DESONIDE
Applicant:Perrigo New York
Ingredient:desonide
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 017426
Medical Subject Heading (MeSH) Categories for 017426
Suppliers and Packaging for NDA: 017426
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESONIDE desonide OINTMENT;TOPICAL 017426 NDA Perrigo New York Inc 45802-423 N 45802-423-35
DESONIDE desonide OINTMENT;TOPICAL 017426 NDA Perrigo New York Inc 45802-423 N 45802-423-37

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
McKesson
Baxter
Cerilliant
Merck
Accenture
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.